Literature DB >> 21550125

The effect of live, attenuated measles vaccine and measles infection on measles antibody levels in serum and CSF of patients with multiple sclerosis or clinically isolated syndrome.

Cecilia Ahlgren1, Anders Odén, Sara Haghighi, Oluf Andersen, Tomas Bergström, Jan Lycke.   

Abstract

High occurrence of measles, rubella and varicella zoster antibodies has been used as a biomarker for MS (the MRZ test). We analyzed measles antibody titres with respect to measles infection/measles vaccination status in 166 patients with MS or clinically isolated syndrome. Fifty blood donors served as controls. Measles vaccination yielded CSF measles antibodies in fewer patients (62%) than measles infection did (87%, p=0.001) and yielded lower measles titres in both serum and CSF (p<0.001). Controls had lower CSF measles titres than patients with measles vaccination alone (p<0.001). Childhood vaccinations probably reduce the sensitivity of the MRZ diagnostic test for MS.
Copyright © 2011 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21550125     DOI: 10.1016/j.jneuroim.2011.04.002

Source DB:  PubMed          Journal:  J Neuroimmunol        ISSN: 0165-5728            Impact factor:   3.478


  4 in total

1.  Multiple sclerosis and environmental risk factors: a case-control study in Iran.

Authors:  Maryam Abbasi; Seyed Massood Nabavi; Seyed Mohammad Fereshtehnejad; Nikan Zerafat Jou; Iman Ansari; Vahid Shayegannejad; Seyed Ehsan Mohammadianinejad; Mahdi Farhoudi; Abbas Noorian; Nazanin Razazian; Mahmoud Abedini; Fardin Faraji
Journal:  Neurol Sci       Date:  2017-08-10       Impact factor: 3.307

2.  JC polyomavirus mutants escape antibody-mediated neutralization.

Authors:  Upasana Ray; Paola Cinque; Simonetta Gerevini; Valeria Longo; Adriano Lazzarin; Sven Schippling; Roland Martin; Christopher B Buck; Diana V Pastrana
Journal:  Sci Transl Med       Date:  2015-09-23       Impact factor: 17.956

Review 3.  Viruses and multiple sclerosis.

Authors:  Jussi Oskari Virtanen; Steve Jacobson
Journal:  CNS Neurol Disord Drug Targets       Date:  2012-08       Impact factor: 4.388

Review 4.  Does disease-irrelevant intrathecal synthesis in multiple sclerosis make sense in the light of tertiary lymphoid organs?

Authors:  Mickael Bonnan
Journal:  Front Neurol       Date:  2014-03-11       Impact factor: 4.003

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.